Ahmar U. Zaidi, MD (Dr. Z)
@drzsicklecell
Followers
5K
Following
13K
Media
1K
Statuses
5K
#sicklecell advocate|blood doc for kids|podcaster|💊 development for sickle cell disease|@tedx speaker|views mine only
Detroit, MI
Joined April 2014
Labs don't show #SickleCell pain. Labs don't show #SickleCell pain. Labs don't show #SickleCell pain. Labs don't show #SickleCell pain. Labs don't show #SickleCell pain. Labs don't show #SickleCell pain. Labs don't show #SickleCell pain. Labs don't show #SickleCell pain.
21
300
1K
#AgiosNews: EMA’s CHMP adopted a positive opinion for our first-in-class PK activator for the treatment of anemia in adult patients with #thalassemia. Decision from European Commission is expected by early 2026. Read our press release: https://t.co/DJVoyzOqY2
1
2
7
Sustained improvements in Hb, hemolytic markers, and sickling kinetics support mitapivat as a disease-modifying treatment in SCD. https://t.co/554vZx0deO
#sicklecelldisease #SCD @ConquerSCD
1
3
14
💉Clinical trial results on crizanlizumab for sickle cell disease (STAND), luspatercept for transfusion-dependent β-thalassaemia (BELIEVE), and mitapivat in sickle cell disease (RISE UP). 👉 https://t.co/MXkpqeLJoc 👉 https://t.co/SXFFkeKVqX 👉 https://t.co/ab2eE0efO5 3/4
1
1
0
🎗️💪Today, on #WorldInheritedBloodDisordersDay, we unite to raise awareness about inherited blood disorders and celebrate the resilience of individuals and families living with conditions like sickle cell disease, thalassaemia, and haemophilia. October cover on #SCD! 1/4
1
3
8
The #SFDA has approved the registration of Pyrukynd (Mitapivat) for the treatment of adult patients with alpha- or beta-thalassemia. https://t.co/ftlna95AE4
1
3
5
Any #SickleCell docs at @huntsmancancer? I’m hearing some horrifying stories about inpatient sickle cell care…
4
1
3
Detroit is a frontrunner to host the 2028 NBA All-Star Game, and the potential economic impact is massive. The 2024 event in Indianapolis generated over $400 million, including $112 million in earned media value—proof that a global event like this fuels business, tourism, and
54
324
2K
The hospital-at-home movement is in its early days. Lots of potential using multimodal #AI remote monitoring and validation via randomized trials https://t.co/zTwIdaAs0b by @FenitN w/ @JayPandit
https://t.co/7twOSjpErE
5
27
59
💪🏽a highlight for me too 💪🏽
Hey y'all! Had to take a break to recover after my trip to the @SCDAAorg Convention in the ATL! It was fun, I made some amazing connections & learned more about #sicklecell! 1 of my highlights was meeting DR. Z @drzsicklecell!😲 Fangirl mode ON! Thankful 4 ALL he does for #SCD🙌🏿!
1
0
8
This is advocacy. ❤️
One of our #SickleCell #warriors had been deported to Rwanda where his disease exploded with severe consequences. Deep gratitude to @RepStephenLynch and his office for helping us bring him back to the US for treatment. Advocacy and political partnership in medicine is essential.
0
0
12
Awareness is good but we need so much action. @akshatdoctor @don_magezi @steven_B256 @wilma_pouline @RareDiseases @RaisingHopeInt2 @uscrfuganda @ddanielroy @drzsicklecell @DrDexPatelSCAF @diaryofaudrey @acweyand @BloodHealthEd @SCDAAorg @dr_evenakato
Today is the 1st day of #SickleCellAwarenessMonth So many awareness angles but let’s not forget that this is arguably the most neglected #GlobalHealth problem A baby with SCD is born every MINUTE Awareness is good but we need so much action. Who’s here for it?
1
6
17
We're thrilled to share the FDA has approved vorasidenib, representing a significant step forward for patients. Congrats to @ServierPharma and the Agios team for their early discovery and development efforts. Read more: https://t.co/4IH1n2cAsZ
1
2
10
Mitapivat was associated with meaningful long-term improvements in key markers of iron homeostasis and erythropoiesis. https://t.co/hZs8MFMrXt
#redcellsironanderythropoiesis
0
2
5
Such important and timely work from the phenomenal @SatokoItoMDPhD @GeorgeGoshuaMD at Goshua Lab @YaleMed @YaleHematology !!! @HemOncFellows @HemOncWomenDocs @drzsicklecell
🚨Excited to share our latest paper in decision science @AjHematology: decreasing alloimmunization-specific mortality for patients with sickle cell disease (SCD) via a shared transfusion resource (STR) to provide antigen + alloantibody history https://t.co/WhgwTQ8XKG
2
2
11
⬇️⬇️⬇️ thanks Dr Azar for always raising awareness and showing unrelenting support for those living with #SickleCell disease!
2023 helped make #SickleCell a part of the national dialogue. In 2024, let’s make it clear that our #SCDWarriors have actually been speaking for decades. Through renewed commitment to advocacy and engagement, let’s make this the year we finally make the world listen.
0
0
12
Absolutely absurd @nbcsnl @kenanthompson
#SickleCell is not a joke and this type of racist nonsense perpetuates the the problem. I am beyond words
10
9
46